Long-Term Safety, Rollover Study of Adjunctive Everolimus in Patients with Tuberous Sclerosis Complex (TSC)-Associated Treatment-Refractory Seizures Who Continue to Benefit from Everolimus Treatment after Completion of EXIST-3
Yazar
Gazri, H. E.
Yapici, Z.
Ikeda, H.
Belousova, E.
Lawson, J. A.
Fan, P. -C.
Herbst, F.
Ridolfi, A.
Üst veri
Tüm öğe kaydını gösterKoleksiyonlar
- Bildiri [64839]